REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,797,477 | +27.0% | 27,437 | +13.2% | 0.01% | +14.3% |
| Q1 2023 | $2,203,083 | +115.2% | 24,231 | -10.1% | 0.01% | +133.3% |
| Q4 2022 | $1,023,717 | -30.4% | 26,947 | -53.9% | 0.00% | -40.0% |
| Q3 2022 | $1,470,000 | +77.5% | 58,499 | +114.7% | 0.01% | +150.0% |
| Q2 2022 | $828,000 | -29.4% | 27,252 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $1,173,000 | +24.3% | 35,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $944,000 | -73.8% | 35,800 | 0.0% | 0.00% | -71.4% |
| Q3 2021 | $3,602,000 | -26.7% | 35,800 | +3.2% | 0.01% | -30.0% |
| Q2 2021 | $4,911,000 | +1366.0% | 34,700 | +932.4% | 0.01% | +900.0% |
| Q1 2021 | $335,000 | -12.3% | 3,361 | +8.8% | 0.00% | 0.0% |
| Q4 2020 | $382,000 | +21.7% | 3,090 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $314,000 | -42.7% | 3,220 | -8.3% | 0.00% | -50.0% |
| Q2 2020 | $548,000 | -89.2% | 3,510 | -90.0% | 0.00% | -88.2% |
| Q1 2020 | $5,052,000 | -17.9% | 35,000 | +16.3% | 0.02% | +13.3% |
| Q4 2019 | $6,153,000 | +154.6% | 30,100 | 0.0% | 0.02% | +114.3% |
| Q3 2019 | $2,417,000 | -6.5% | 30,100 | +9.9% | 0.01% | 0.0% |
| Q2 2019 | $2,585,000 | +22.9% | 27,400 | +11.4% | 0.01% | +16.7% |
| Q1 2019 | $2,103,000 | +97.3% | 24,600 | +29.5% | 0.01% | +100.0% |
| Q4 2018 | $1,066,000 | -19.5% | 19,000 | +17.3% | 0.00% | -25.0% |
| Q3 2018 | $1,325,000 | +133.7% | 16,200 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $567,000 | – | 16,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |